Cancer Research UK
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 2002-01-01
- Employees
- 1K
- Market Cap
- -
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2005-03-04
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 25
- Registration Number
- NCT00104897
- Locations
- 🇬🇧
Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust, Cambridge, England, United Kingdom
🇬🇧Royal Marsden NHS Foundation Trust - Surrey, Sutton, England, United Kingdom
Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2004-09-16
- Last Posted Date
- 2013-08-07
- Lead Sponsor
- Cancer Research UK
- Registration Number
- NCT00004209
- Locations
- 🇬🇧
Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom
🇬🇧Royal Marsden NHS Trust, London, England, United Kingdom
Bryostatin 1 In Treating Patients With Progressive Kidney Cancer
- Conditions
- Kidney Cancer
- First Posted Date
- 2004-08-09
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Cancer Research UK
- Registration Number
- NCT00005056
- Locations
- 🇬🇧
Oxford Radcliffe Hospital, Oxford, England, United Kingdom
🇬🇧Imperial Cancer Research Fund Medical Oncology Unit, Oxford, England, United Kingdom
Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2004-06-09
- Last Posted Date
- 2013-08-07
- Lead Sponsor
- Cancer Research UK
- Registration Number
- NCT00002460
- Locations
- 🇬🇧
Clatterbridge Centre for Oncology NHS Trust, Merseyside, England, United Kingdom
🇧🇪Institut Jules Bordet, Brussels, Belgium
🇬🇧Royal Marsden NHS Trust, London, England, United Kingdom
Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2004-06-09
- Last Posted Date
- 2013-08-02
- Lead Sponsor
- Cancer Research UK
- Registration Number
- NCT00002476
- Locations
- 🇬🇧
Derriford Hospital, Plymouth, England, United Kingdom
🇬🇧Southend General Hospital, Westcliff-On-Sea, England, United Kingdom
🇬🇧Royal Victoria Hospital, Belfast, Northern Ireland, United Kingdom
Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain
- Conditions
- Metastatic CancerPainProstate Cancer
- First Posted Date
- 2004-05-19
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 580
- Registration Number
- NCT00082927
- Locations
- 🇬🇧
Cancer Care Centre at York Hospital, York, England, United Kingdom
🇬🇧Mount Vernon Cancer Centre at Mount Vernon Hospital, Northwood, England, United Kingdom
🇬🇧West Cumberland Hospital, Whitehaven, England, United Kingdom
Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer
- Conditions
- Ovarian Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-08-26
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 30
- Registration Number
- NCT00004876
- Locations
- 🇬🇧
Oxford Radcliffe Hospital, Oxford, England, United Kingdom
Suramin in Treating Patients With Recurrent Bladder Cancer
- Conditions
- Bladder Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 15
- Registration Number
- NCT00006476
- Locations
- 🇬🇧
Oxford Radcliffe Hospital, Oxford, England, United Kingdom
Geldanamycin Analogue in Treating Patients With Advanced Cancer
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Cancer Research UK
- Registration Number
- NCT00003969
- Locations
- 🇬🇧
Royal Marsden NHS Foundation Trust - London, London, England, United Kingdom
Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 508
- Registration Number
- NCT00032175
- Locations
- 🇬🇧
Singleton Hospital of the Swansea NHS Trust, Swansea, Wales, United Kingdom
🇬🇧Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, England, United Kingdom
🇬🇧Royal United Hospital, Bath, England, United Kingdom